[Federal Register Volume 60, Number 30 (Tuesday, February 14, 1995)] [Notices] [Pages 8413-8414] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 95-3626] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated July 19, 1994, and published in the Federal Register on July 28, 1994 (59 FR 38492), Dupont Pharmaceuticals, The Dupont Merck Pharmaceutical Company, 1000 Stewart Avenue, Garden City, New York 11530, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Oxycodone (9143)........................................... II Hydrocodone (9193)......................................... II Oxymorphone (9652)......................................... II ------------------------------------------------------------------------ No comments or objections have been received. Therefore, pursuant to Section [[Page 8414]] 303 of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and Title 21, Code of Federal Regulations, Section 1301.54(e), the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted. Dated: February 6, 1995. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 95-3626 Filed 2-13-95; 8:45 am] BILLING CODE 4410-09-M